Clinical Trial Update: An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation [NA]

View source ↗

Summary

An open-label clinical trial comparing adaptive versus conventional deep brain stimulation for Parkinson's disease has been withdrawn. Sponsor: Newronika.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Newronika | Conditions: Parkinson Disease | NA | Status: WITHDRAWN